Joshua Ziel

Joshua Ziel has over 8 years of experience in the pharmaceutical industry. Joshua began their career in 2014 as a Writer at WPP, where they held positions as Associate Director and Director before becoming Vice President. In 2018, they joined Syneos Health as Senior Vice President and later became Executive Vice President, where they were responsible for doubling the BU revenue from 2018 to 2022. In 2022, they joined Aerami Therapeutics as VP, Program Development, with accountability for strategic planning and execution for pipeline development.

Joshua Ziel attended Duke University from 2005 to 2011, where they earned a Doctor of Philosophy (Ph.D) in Biology. Prior to that, they attended University of Michigan from 2001 to 2005, where they earned a B.S. in Cell and Molecular Biology, High Honors. After graduating from Duke University, Joshua attended New York University from 2011 to 2014, where they completed a Postdoctoral Fellowship in Immunology.